**Core Concept:**
Differentiated thyroid cancer is a type of thyroid cancer that originates from the cells of the thyroid gland, which are specialized to produce thyroid hormones (T3 and T4). Treatment options for differentiated thyroid cancer depend on the cancer stage and the patient's overall health.

**Why the Correct Answer is Right:**
The correct answer, **D. Radioactive iodine (I-131)**, is a nuclear medicine therapy used in the treatment of differentiated thyroid cancer. I-131 is a radioisotope that selectively concentrates in the thyroid gland due to the high iodine-uptake by the thyroid cells. Once in the thyroid, the I-131 emits beta radiation that destroys the cancer cells by inducing cell death (apoptosis). This targeted therapy minimizes damage to healthy thyroid tissue and reduces side effects.

**Why Each Wrong Option is Incorrect:**

A. **Calcitonin (Cabergoline):** Calcitonin is a hormone that regulates calcium levels in the body. It is not used in the treatment of thyroid cancer but rather for medullary thyroid cancer (a different type of thyroid cancer).

B. **Radical surgery:** While surgery is a key part of thyroid cancer treatment, it is not a targeted therapy like I-131. Surgery aims to remove the cancerous thyroid tissue and local lymph nodes, and is usually combined with other treatments like radioactive iodine and/or thyroid hormone suppression therapy.

C. **Thyroid hormone suppression therapy:** This treatment aims to lower thyroid hormone levels to prevent the cancer from spreading and reduce symptoms. It is often used after surgery, radioactive iodine therapy, and/or chemotherapy. However, it is not a direct cancer treatment but rather a supportive therapy.

**Clinical Pearl:**
It is essential for medical students and residents to understand the nuanced differences between various cancer treatments, as each treatment has its indications and contraindications based on the cancer type, stage, and overall patient health. This enables the healthcare team to choose the most effective and least harmful treatment plan for each patient.